Palisade Bio (PALI) Short term Debt (2010 - 2025)
Palisade Bio (PALI) reported Short term Debt of $235000.0 for Q3 2025, up 256.06% quarter-over-quarter from $66000.0 in Q2 2025.
Palisade Bio (PALI) Short term Debt (2010 - 2025) Analysis & Trends
Palisade Bio (PALI) has 11 years of Short term Debt data on file, last reported at $235000.0 in Q3 2025.
- Short term Debt for Q3 2025 came in at $235000.0, changed N/A year-over-year; the trailing twelve-month figure through Sep 2025 was $235000.0 (changed N/A YoY), and the FY2023 annual result was $143000.0, changed N/A from the prior year.
- Short term Debt grew to $235000.0 in Q3 2025 per PALI's latest filing, from $66000.0 in the prior quarter.
- Over five years, Short term Debt peaked at $1.1 million in Q2 2021 and troughed at $66000.0 in Q2 2025.
- A 4-year average of $254125.0 and a median of $143000.0 in 2023 frame the typical range for Short term Debt.
- The sharpest annual moves came in 2021 and 2025: Short term Debt sank 91.69% in 2021, then tumbled 51.75% in 2025.
- A 4-year view of Short term Debt shows it stood at $87000.0 in 2021, then soared by 64.37% to $143000.0 in 2023, then rose by 4.2% to $149000.0 in 2024, then jumped by 57.72% to $235000.0 in 2025.
- Business Quant data shows PALI's Short term Debt at $235000.0 in Q3 2025, $66000.0 in Q2 2025, and $69000.0 in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Palisade Bio | 357.48 Mn | 227.91 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 235,000.00 |
| Jun 30, 2025 | 66,000.00 |
| Mar 31, 2025 | 69,000.00 |
| Jun 30, 2024 | 149,000.00 |
| Mar 31, 2024 | 143,000.00 |
| Dec 31, 2023 | 143,000.00 |
| Dec 31, 2021 | 87,000.00 |
| Jun 30, 2021 | 1.14 Mn |
| Dec 31, 2020 | 1.05 Mn |
| Mar 31, 2017 | 2.53 Mn |
| Dec 31, 2016 | 3.71 Mn |
| Sep 30, 2016 | 4.83 Mn |
| Jun 30, 2016 | 5.91 Mn |
| Mar 31, 2016 | 4.47 Mn |
| Dec 31, 2015 | 4.55 Mn |
| Sep 30, 2015 | 4.46 Mn |
| Jun 30, 2015 | 3.17 Mn |
| Mar 31, 2015 | 1.93 Mn |
| Dec 31, 2014 | 730,012.00 |
| Jun 30, 2014 | 2.95 Mn |